Reactivation of herpesviruses during COVID‐19: A systematic review and meta‐analysis
To provide a comprehensive systematic review and meta‐analysis regarding the cumulative
incidence (incidence proportion) of human herpesvirus (HHV) reactivation among patients …
incidence (incidence proportion) of human herpesvirus (HHV) reactivation among patients …
EBV and Lymphomagenesis
DG Sausen, A Basith, S Muqeemuddin - Cancers, 2023 - mdpi.com
Simple Summary Epstein–Barr virus is a highly prevalent virus associated with a multitude of
diseases, including autoimmune conditions such as multiple sclerosis and many types of …
diseases, including autoimmune conditions such as multiple sclerosis and many types of …
Therapeutic challenges in peripheral T-cell lymphoma
Y Luan, X Li, Y Luan, J Luo, Q Dong, S Ye, Y Li, Y Li… - Molecular Cancer, 2024 - Springer
Peripheral T-cell lymphoma (PTCL) is a rare and heterogeneous group of hematological
malignancies. Compared to our knowledge of B-cell tumors, our understanding of T-cell …
malignancies. Compared to our knowledge of B-cell tumors, our understanding of T-cell …
[HTML][HTML] T cell-mediated immunity during Epstein–Barr virus infections in children
M Liu, R Wang, Z Xie - Infection, Genetics and Evolution, 2023 - Elsevier
Epstein–Barr virus (EBV) infection is extremely common worldwide, with approximately 90%
of adults testing positive for EBV antibodies. Human are susceptible to EBV infection, and …
of adults testing positive for EBV antibodies. Human are susceptible to EBV infection, and …
[HTML][HTML] Epstein–Barr virus and COVID‐19
Dear Editor, As the number of infections with the novel coronavirus, severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) rise beyond 430 million documented cases, 1 the …
syndrome coronavirus 2 (SARS‐CoV‐2) rise beyond 430 million documented cases, 1 the …
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma
Z Chen, H Huang, H Huang, L Yu, H Weng, J Xiao… - Leukemia, 2024 - nature.com
Natural killer/T-cell lymphoma (NKTCL) is a highly heterogeneous disease with a poor
prognosis. However, the genomic characteristics and proper treatment strategies for non …
prognosis. However, the genomic characteristics and proper treatment strategies for non …
EBV-positive Nodal T-Cell and NK-Cell Lymphoma: A Study of 26 Cases Including a Subset With Strong CD30 Expression Mimicking Anaplastic Large Cell …
F Yu, J Wang, Z Ke, Y Zhang, L Xu… - The American Journal …, 2024 - journals.lww.com
Abstract Epstein-Barr virus (EBV)-positive nodal T-cell and NK-cell lymphoma is a rare
neoplasm of cytotoxic T-cell or NK-cell lineage. Here, we report 26 cases affecting 14 men …
neoplasm of cytotoxic T-cell or NK-cell lineage. Here, we report 26 cases affecting 14 men …
First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 …
XP Tian, J Cai, Y Xia, YC Zhang, L Wang… - The Lancet …, 2024 - thelancet.com
Background Programmed cell death protein 1 (PD-1) inhibitor sintilimab is effective in
relapsed and refractory extranodal natural killer/T cell lymphoma (ENKTL), nasal type. We …
relapsed and refractory extranodal natural killer/T cell lymphoma (ENKTL), nasal type. We …
Rational targets of therapy in extranodal NK/T-cell lymphoma
A Major, P Porcu, BM Haverkos - Cancers, 2023 - mdpi.com
Simple Summary Extranodal NK/T-cell lymphoma (ENKTL) is an aggressive blood cancer
with poor survival rates, particularly for patients with advanced-stage and relapsed disease …
with poor survival rates, particularly for patients with advanced-stage and relapsed disease …
Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progression
Z Chen, H Huang, H Hong, H Huang, H Weng, L Yu… - Genome Medicine, 2024 - Springer
Background Natural killer/T cell lymphoma (NKTCL) is a clinically and genetically
heterogeneous disease with poor prognosis. Genome sequencing and mutation …
heterogeneous disease with poor prognosis. Genome sequencing and mutation …